Functional selectivity of cannabinoids at CB1 receptors: Comprehensive analysis of G proteins, β-arrestin and cAMP signalling dynamics in HEK293T cells
Open Access
- 6 March 2026
- journal article
- Published by Elsevier in European Journal of Pharmacology
- Vol. 1019, 178735
Abstract
No abstract availableKeywords
This publication has 51 references indexed in Scilit:
- Snapshot of the cannabinoid receptor 1-arrestin complex unravels the biased signaling mechanismCell, 2023
- Diversity of molecular targets and signaling pathways for CBDPharmacology Research & Perspectives, 2020
- Behavioral effects of the cannabinoid CB1receptor allosteric modulator ORG27569 in ratsPharmacology Research & Perspectives, 2014
- Efficacy and safety of the weight-loss drug rimonabant: a meta-analysis of randomised trialsThe Lancet, 2007
- Agonistic Properties of Cannabidiol at 5-HT1a ReceptorsNeurochemical Research, 2005
- The endocannabinoid signaling system: Pharmacological and therapeutic aspectsPharmacology Biochemistry and Behavior, 2005
- Inverse agonism and neutral antagonism at cannabinoid CB1 receptorsLife Sciences, 2005
- Inhibitory effects of SR141716A on G-protein activation in rat brainEuropean Journal of Pharmacology, 2001
- LY320135, a Novel Cannabinoid CB1 Receptor Antagonist, Unmasks Coupling of the CB1 Receptor to Stimulation of cAMP AccumulationThe Journal of Pharmacology and Experimental Therapeutics, 1998
- Enhancement of membrane insertion and function in a type IIIb membrane protein following introduction of a cleavable signal peptide.Journal of Biological Chemistry, 1992